Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study

PeerJ - Tập 9 - Trang e10910
Bilge Sümbül1, Hilmi Erdem Sümbül2, Ramazan Azim Okyay3, Erdinç Gülümsek2, Ahmet Rıza Şahin4, Barış Boral5, Burhan Fatih Koçyiğit6, Mostafa Alfishawy7, Jeffrey Gold8, Ali Muhittin Taşdoğan9
1Department of Medical Microbiology, Bezmialem Vakıf University Faculty of Medicine, Istanbul, Turkey
2Department of Internal Medicine, University of Health Sciences, Adana Health Practice and Research Center, Adana, Turkey
3Department of Public Health, Kahramanmaraş Sütçü İmam University, Faculty of Medicine, Kahramanmaraş, Turkey
4Department of Infectious Diseases and Clinical Microbiology, Kahramanmaraş Sütçü İmam University, Faculty of Medicine, Kahramanmaraş, Turkey
5Department of Microbiology, University of Health Sciences, Adana Health Practice and Research Center, Adana, Turkey
6Department of Physical Medicine and Rehabilitation, Kahramanmaraş Sütçü İmam University, Faculty of Medicine, Kahramanmaraş, Turkey
7Infectious Diseases Consultants and Academic Researchers of Egypt (IDCARE), Cairo, Egypt
8World Organization, , , Watkinsville, GA, USA
9Department of Anesthesiology and Reanimation, Hasan Kalyoncu University, Faculty of Health Sciences, Gaziantep, Turkey

Tóm tắt

Background

There is growing evidence indicating that children are less affected from COVID-19. Some authors speculate that childhood vaccinations may provide some cross-protection against COVID-19. In this study, our aim was to compare the circulating antibody titers for multiple childhood vaccine antigens, as an indicator of the state of immune memory between patients with COVID-19 and healthy controls, with a specific aim to identify the association between disease severity and antibody titrations which may indicate a protective function related to vaccine or disease induced memory.

Methods

This study is a case-control study including 53 patients with COVID-19 and 40 healthy volunteers. COVID-19 severity was divided into three groups: asymptomatic, mild and severe. We measured the same set of antibody titers for vaccine antigens, and a set of biochemical and infection markers, in both the case and control groups.

Results

Rubella (p = 0.003), pneumococcus (p = 0.002), and Bordetella pertussis (p < 0.0001) titers were found to be significantly lower in the case group than the control group. There was a significant decline in pneumococcus titers with severity of disease (p = 0.021) and a significant association with disease severity for Bordetella pertussis titers (p = 0.014) among COVID patients. Levels of AST, procalcitonin, ferritin and D-dimer significantly increased with the disease severity.

Discussion

Our study supports the hypothesis that pre-existing immune memory, as monitored using circulating antibodies, acquired from childhood vaccinations, or past infections confer some protection against COVID-19. Randomized controlled studies are needed to support a definitive conclusion.

Từ khóa


Tài liệu tham khảo

Aringer, 2020, Inflammatory markers in systemic lupus erythematosus, Journal of Autoimmunity, 110, 102374, 10.1016/j.jaut.2019.102374

Bodmer, 2018, Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model, Virology, 521, 99, 10.1016/j.virol.2018.05.028

Cauchi, 2018, Non-specific effects of live attenuated pertussis vaccine against heterologous infectious and inflammatory diseases, Frontiers in Immunology, 9, 2872, 10.3389/fimmu.2018.02872

Di Filippo, 2020, Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19, Endocrine, 68, 475, 10.1007/s12020-020-02383-5

Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infectious Diseases, 20, 533, 10.1016/S1473-3099(20)30120-1

Dong, 2020, Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China, Pediatrics, 2020, e20200702, 10.1542/peds.2020–0702

Franklin, 2020, Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19, Medrxiv Preprint, 10.1101/2020.04.10.20053207

Gao, 2020, Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19, Journal of Medical Virology, 92, 791, 10.1002/jmv.25770

Gold, 2020, MMR vaccine appears to confer strong protection from COVID-19: few deaths from SARS-CoV-2 in highly vaccinated populations, ResearchGate Preprint, 10.13140/RG.2.2.32128.25607

Gold, 2020, Analysis of measles-mumps-rubella (MMR) titers of recovered COVID-19 patients, MBio, 11, e02628-20, 10.1128/mBio.02628-20

Guan, 2020, Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia, Zhonghua Gan Zang Bing Za Zhi, 28, 100, 10.3760/cma.j.issn.1007-3418.2020.02.002

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Kozak, 2020, Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario, Journal of Clinical Virology, 126, 104338, 10.1016/j.jcv.2020.104338

Lapić, 2020, Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis, Clinical Chemistry and Laboratory Medicine, 58, 1146, 10.1515/cclm-2020-0620

Li, 2020, The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis, Progress in Cardiovascular Diseases, 63, 518, 10.1016/j.pcad.2020.04.008

Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis, Clinica Chimica Acta, 506, 145, 10.1016/j.cca.2020.03.022

Lippi, 2020, Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis, Clinica Chimica Acta, 505, 190, 10.1016/j.cca.2020.03.004

Long, 2020, Cardiovascular complications in COVID-19, American Journal of Emergency Medicine, 38, 1504, 10.1016/j.ajem.2020.04.048

Luo, 2020, Low blood sodium increases risk and severity of COVID-19: a systematic review, meta-analysis and retrospective cohort study, Medrxiv Preprint, 10.1101/2020.05.18.20102509

Lyu, 2020, Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection?, Medical Hypotheses, 143, 109842, 10.1016/j.mehy.2020.109842

Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0

Miller, 2020, Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study, MedRxiv, 27, 441, 10.1101/2020.03.24.20042937

Netea, 2016, Trained immunity: a program of innate immune memory in health and disease, Science, 352, aaf1098, 10.1126/science.aaf1098

Netea, 2017, Trained immunity: an ancient way of remembering, Cell Host & Microbe, 21, 297, 10.1016/j.chom.2017.02.003

Okyay, 2020, Why are children less affected by COVID-19? Could there be an overlooked bacterial co-infection?, Eurasian Journal of Medicine and Oncology, 4, 104, 10.14744/ejmo.2020.40743

Panigada, 2020, Hypercoagulability of COVID-19 patients in Intensive care unit: a report of thromboelastography findings and other parameters of hemostasis, Journal of Thrombosis and Haemostasis, 18, 1738, 10.1111/jth.14850

Recalcati, 2020, Cutaneous manifestations in COVID-19: a first perspective, Journal of the European Academy of Dermatology and Venereology, 34, e212, 10.1111/jdv.16387

Root-Bernstein, 2020, Possible cross-reactivity between SARS-CoV-2 proteins, CRM197 and proteins in pneumococcal vaccines may protect against symptomatic SARS-CoV-2 disease and death, Vaccines, 8, 559, 10.3390/vaccines8040559

Salman, 2020, Routine childhood immunization may protect against COVID-19, Medical Hypotheses, 140, 109689, 10.1016/j.mehy.2020.109689

Spiezia, 2020, COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure, Thrombosis and Haemostasis, 120, 998, 10.1055/s-0040-1714350

Terpos, 2020, Hematological findings and complications of COVID-19, American Journal of Hematology, 95, 834, 10.1002/ajh.25829

Velavan, 2020, Mild versus severe COVID-19: laboratory markers, International Journal of Infectious Diseases, 95, 304, 10.1016/j.ijid.2020.04.061

Wang, 2020a, Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients, Military Medical Research, 7, 28, 10.1186/s40779-020-00256-6

Wang, 2020b, SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19, Journal of Hepatology, 73, 807, 10.1016/j.jhep.2020.05.002

World Health Organization, 2020, WHO and UNICEF estimates of national immunization coverage

Xu, 2020, Mechanism of thrombocytopenia in COVID-19 patients, Annals of Hematology, 99, 1205, 10.1007/s00277-020-04019-0

Zhu, 2020, Co-infection with respiratory pathogens among COVID-2019 cases, Virus Research, 285, 198005, 10.1016/j.virusres.2020.198005